Download PDF
Horm Metab Res 1993; 25(1): 37-39
DOI: 10.1055/s-2007-1002042
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Lack of Effect of Octreotide on Parathyroid Hormone Levels and Urinary Excretion of Epidermal Growth Factor

M. A. Botana, L. Castillo, C. Pesquera, J. Freijanes, J. A. Amado, J. González-Macías
  • Endocrine Unit, Department of Internal Medicine, Valdecilla Hospital, University of Cantabria, Santander, Spain
Further Information

Publication History

1991

1992

Publication Date:
14 March 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

To determine whether octreotide may acutely modify calcium homeostasis and/or inhibit the EGF production by the kidney, a subcutaneous injection of octreotide (100 μg) was administered to ten healthy volunteers. Blood and urine samples were collected at -30, 0, 60, 90, 120 and 180 minutes. Serum insulin, intact PTH, osteocalcin, total and ionized calcium and urinary EGF and creatinine were measured.

There was no modification in serum PTH, osteocalcin and total or ionized calcium. There was no significant modification of urinary EGF, although a trend to decrease was evidenced.

Key words

Octreotide - Parathyroid Hormone - Osteocalcin - Calcium - Epidermal Growth Factor

      >